# DROXIDOPA
> **ANDA215265** · Abbreviated New Drug Application (Generic) · Sponsor: ADAPTIS · Approved 2021-11-01
## Drug
- **FDA Application Number:** ANDA215265
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DROXIDOPA
- **Generic name:** DROXIDOPA
- **Active ingredients:** DROXIDOPA
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ADAPTIS
- **Manufacturer:** Slate Run Pharmaceuticals, LLC
- **First approval:** 2021-11-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215265)
---
*MORVS · CC0 1.0*